SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-173673
Filing Date
2019-06-14
Accepted
2019-06-14 16:08:01
Documents
5
Period of Report
2019-06-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d764937d8k.htm 8-K 31273
2 EX-1.1 d764937dex11.htm EX-1.1 184363
3 EX-5.1 d764937dex51.htm EX-5.1 12047
4 GRAPHIC g764937g46l45.jpg GRAPHIC 3849
5 GRAPHIC g764937gra10.jpg GRAPHIC 2253
  Complete submission text file 0001193125-19-173673.txt   237599
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37465 | Film No.: 19898952
SIC: 2834 Pharmaceutical Preparations